Usage of brand-name drugs has declined but seniors are still paying more although they are receiving less, according to a report by the U.S. Department of Health & Human Services (DHHS).
The Office of Inspector General (OIG) found:
Total reimbursements for all brand-name drugs in Part D increased 77 percent from 2011 to...